Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology OnlineFirst articles

08.12.2018 | Original Article

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

Somatostatin analogs are the mainstay of medical therapy for patients with acromegaly and for control of symptoms related to hypersecretion of bioactive compounds, and proliferation in patients with functioning gastroenteropancreatic …

08.12.2018 | Original Article Open Access

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

Colorectal cancer is the second most frequently diagnosed cancer in males and the third most frequently diagnosed cancer in females [ 1 ]. The disease remains the second most frequent cause of cancer death in males and the third most frequent cause …

08.12.2018 | Original Article

A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer

The Src family of kinases (SFKs) includes nine highly related, membrane-associated non-receptor tyrosine kinases that are involved in intracellular signaling pathways that regulate cell proliferation, motility and invasion, angiogenesis, and …

08.12.2018 | Original Article

Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer

Gastric cancer is the fifth most common malignancy and the third most common cause of cancer death worldwide [ 1 ]. Most patients present with inoperable advanced or metastatic disease [ 2 – 4 ]. This is because early gastric cancer generally has …

06.12.2018 | Original Article

Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205)

Adjuvant chemotherapy including oxaliplatin is recommended in patients with stage II or III colorectal cancer [ 1 – 5 ]. Combined 5FU and oxaliplatin chemotherapy (FOLFOX) and capecitabine and oxaliplatin chemotherapy (Capeox) are widely used for …

Aktuelle Ausgaben

Über diese Zeitschrift

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise